2012 2015 Blogging Capital 
Xconomy
MARCH 28, 2019
Founders Jared Tagney and Joshua Windmiller, who met while in grad school at UC San Diego, started the company in 2012 as Electrozyme. The company began focusing on the technology it is currently developing in 2015, Tagney said. Biosensor startup Biolinq said Thursday it has raised $4.75
Xconomy
JANUARY 24, 2017
In the mega-class of 177 biotechs that went public from 2012 through 2015, women held 11 percent of the board seats, according to their 2016 regulatory filings. That’s according to British recruitment firm Liftstream and its new study of biotech companies that went public in the recent boom years.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Eric Greenspan
JANUARY 24, 2016
After being what I assume is the subject of one or more of Seth David’s emotionally charged blog posts, I’ve decided it’s time to respond. This blog post is for information purposes only and my only intention is to move forward. In 2012, my company plundered and it was horrific…bygones.
Xconomy
JULY 26, 2016
LendingClub helped to pioneer the model, saying in November 2012 that it had surpassed $1 billion in loans issued since 2006, when it was founded. billion in loans since 2012, when its business “morphed” into an alternative lender, according to founder and CEO Dave Gilbert. million in 2012 to more than $59 million in 2015.
Xconomy
JULY 26, 2016
LendingClub helped to pioneer the model, saying in November 2012 that it had surpassed $1 billion in loans issued since 2006, when it was founded. billion in loans since 2012, when its business “morphed” into an alternative lender, according to founder and CEO Dave Gilbert. million in 2012 to more than $59 million in 2015.
Xconomy
OCTOBER 27, 2016
Venture capital firms have increased their agtech investments by 80 percent since 2012, bringing total VC investment in the sector to a total of $3 billion in 2015, according to a new report from Boston Consulting Group and AgFunder, an online investment marketplace for agriculture technology.
Xconomy
OCTOBER 14, 2016
That means in three months, Bristol has lost a third of its value, equivalent to about $40 billion in market capitalization. Illumina fended off a hostile takeover bid from Roche back in February 2012, and over the next three years shares went from about $51 apiece to as high as $219.30 in July 2015. The reason?
Expert insights. Personalized for you.
103 
Let's personalize your content